Compare DVA & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | XPEV |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | China |
| Employees | N/A | 19884 |
| Industry | Misc Health and Biotechnology Services | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 12.6B |
| IPO Year | 2003 | N/A |
| Metric | DVA | XPEV |
|---|---|---|
| Price | $233.49 | $13.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $156.75 | $23.08 |
| AVG Volume (30 Days) | 701.6K | ★ 6.8M |
| Earning Date | 05-05-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $13,643,069,000.00 | N/A |
| Revenue This Year | $3.85 | $25.76 |
| Revenue Next Year | $3.07 | $25.98 |
| P/E Ratio | $82.14 | ★ N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $101.00 | $11.77 |
| 52 Week High | $238.64 | $28.20 |
| Indicator | DVA | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 78.56 | 41.43 |
| Support Level | $145.58 | $11.77 |
| Resistance Level | N/A | $18.35 |
| Average True Range (ATR) | 6.03 | 0.45 |
| MACD | 1.61 | 0.10 |
| Stochastic Oscillator | 78.96 | 61.79 |
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.